NO20024576L - Fremgangsmate for a inhibere angiogenese og tumorvekst - Google Patents

Fremgangsmate for a inhibere angiogenese og tumorvekst

Info

Publication number
NO20024576L
NO20024576L NO20024576A NO20024576A NO20024576L NO 20024576 L NO20024576 L NO 20024576L NO 20024576 A NO20024576 A NO 20024576A NO 20024576 A NO20024576 A NO 20024576A NO 20024576 L NO20024576 L NO 20024576L
Authority
NO
Norway
Prior art keywords
tumor growth
inhibiting angiogenesis
angiogenesis
inhibiting
tumor
Prior art date
Application number
NO20024576A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024576D0 (no
Inventor
Dale L Boger
David A Cheresh
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of NO20024576D0 publication Critical patent/NO20024576D0/no
Publication of NO20024576L publication Critical patent/NO20024576L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20024576A 2000-03-27 2002-09-24 Fremgangsmate for a inhibere angiogenese og tumorvekst NO20024576L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19226000P 2000-03-27 2000-03-27
PCT/US2001/009785 WO2001072297A1 (en) 2000-03-27 2001-03-27 Methods for inhibiting angiogenesis and tumor growth

Publications (2)

Publication Number Publication Date
NO20024576D0 NO20024576D0 (no) 2002-09-24
NO20024576L true NO20024576L (no) 2002-11-20

Family

ID=22708924

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20024576A NO20024576L (no) 2000-03-27 2002-09-24 Fremgangsmate for a inhibere angiogenese og tumorvekst
NO20024578A NO328969B1 (no) 2000-03-27 2002-09-24 Forbindelser, sammensetninger og anvendelser derav

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20024578A NO328969B1 (no) 2000-03-27 2002-09-24 Forbindelser, sammensetninger og anvendelser derav

Country Status (15)

Country Link
EP (2) EP1272173A4 (pl)
JP (2) JP2003528850A (pl)
KR (2) KR100767616B1 (pl)
CN (2) CN1229339C (pl)
AU (4) AU2001249499B2 (pl)
CA (3) CA2403630C (pl)
CZ (2) CZ20023510A3 (pl)
HU (2) HUP0301621A3 (pl)
MX (2) MXPA02009504A (pl)
NO (2) NO20024576L (pl)
PL (2) PL205134B1 (pl)
RU (2) RU2269339C2 (pl)
SK (2) SK14852002A3 (pl)
WO (2) WO2001072297A1 (pl)
ZA (2) ZA200208628B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2235611B2 (es) * 2003-07-25 2006-07-16 Universidade De Santiago De Compostela Metodo cuantitativo para la deteccion de yesotoxinas en productos pesqueros basado en la activacion que producen en las fosfodiesterasas.
UA82561C2 (uk) 2003-10-23 2008-04-25 Оцука Фармасьютикалз Ко., Лтд. Стерильна ін'єкційна композиція арипіпразолу з контрольованим вивільненням, спосіб її виготовлення та спосіб лікування шизофренії
RU2287341C1 (ru) * 2005-03-01 2006-11-20 Автономная некоммерческая организация Научно-технический центр "Фармбиопресс" Ингибитор ангиогенеза, антиангиогенная фармацевтическая композиция на его основе и способ лечения злокачественных новообразований
SI2170279T1 (en) 2007-07-31 2018-04-30 Otsuka Pharmaceutical Co., Ltd. Methods for producing aripiprazole suspension and freeze-dried formulation
RU2404794C2 (ru) * 2008-11-27 2010-11-27 Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова Федерального агентства по здравоохранению и социальному развитию (ГОУВПО ММА им. И.М. Сеченова Росздрава) Вагинальные суппозитории для лечения рака шейки матки

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
JPH05125029A (ja) * 1991-11-06 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアミド化合物又はその塩
GB9308695D0 (en) * 1993-04-27 1993-06-09 Celltech Ltd Peptidyl derivatives
UA44258C2 (uk) * 1993-10-15 2002-02-15 Рон-Пуленк Рорер Фармасьютікалз Інк. Антитромботичні азациклоалкілалканоілпептиди та псевдопептиди, фармацевтична композиція, що їх містить, спосіб профілактики або лікування тромбозу у ссавців (варіанти)
GB9405076D0 (en) * 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
AUPO104496A0 (en) * 1996-07-17 1996-08-08 Biomolecular Research Institute Limited Angiogenic inhibitory compounds
JP2002514180A (ja) * 1996-09-04 2002-05-14 ワーナー―ランバート・コンパニー マトリックスメタロプロテイナーゼを阻害するための化合物およびその方法
EP0968423A4 (en) * 1997-02-07 2002-10-30 Scripps Research Inst CONVERGENT SYNTHESIS OF A COMBINATORY LIBRARY
JP2002509881A (ja) * 1998-03-27 2002-04-02 ジェネンテク・インコーポレイテッド Ｃｄ１１／ｃｄ１８接着レセプター媒介疾患の治療用アンタゴニスト

Also Published As

Publication number Publication date
AU2001249499B2 (en) 2005-04-21
PL358272A1 (pl) 2004-08-09
HUP0301621A2 (hu) 2003-09-29
NO328969B1 (no) 2010-06-28
KR20020084258A (ko) 2002-11-04
CA2659030A1 (en) 2001-10-04
EP1272173A4 (en) 2006-05-03
CA2403871A1 (en) 2001-10-04
CN1229339C (zh) 2005-11-30
HUP0301621A3 (en) 2009-06-29
KR100776185B1 (ko) 2007-11-16
NO20024576D0 (no) 2002-09-24
AU5101801A (en) 2001-10-08
CZ20023509A3 (cs) 2003-06-18
NO20024578L (no) 2002-11-20
SK14842002A3 (sk) 2003-04-01
CN1245967C (zh) 2006-03-22
AU2001251018B2 (en) 2005-12-01
ZA200208626B (en) 2004-02-16
CA2403871C (en) 2010-05-11
EP1272173A1 (en) 2003-01-08
AU4949901A (en) 2001-10-08
WO2001072297A1 (en) 2001-10-04
CA2403630C (en) 2009-05-26
NO20024578D0 (no) 2002-09-24
PL205134B1 (pl) 2010-03-31
ZA200208628B (en) 2004-02-12
JP2003528850A (ja) 2003-09-30
CN1429106A (zh) 2003-07-09
SK14852002A3 (sk) 2003-06-03
KR100767616B1 (ko) 2007-10-18
MXPA02009510A (es) 2003-05-21
HUP0301797A3 (en) 2010-09-28
EP1276713A1 (en) 2003-01-22
PL366316A1 (pl) 2005-01-24
CA2403630A1 (en) 2001-10-04
JP2003528140A (ja) 2003-09-24
EP1276713A4 (en) 2006-05-03
RU2276133C2 (ru) 2006-05-10
CN1441777A (zh) 2003-09-10
CZ20023510A3 (cs) 2003-03-12
WO2001072699A1 (en) 2001-10-04
HUP0301797A2 (hu) 2003-09-29
MXPA02009504A (es) 2003-05-21
RU2269339C2 (ru) 2006-02-10
KR20020091156A (ko) 2002-12-05
RU2002128751A (ru) 2004-03-10

Similar Documents

Publication Publication Date Title
GB2376076B (en) Method and apparatus for cancellation of borehole effects due to a tilted or transverse magnetic dipole
NO20015547D0 (no) Halvsyntetisk fremgangsmåte og nye forbindelser
NO20022188L (no) Flerlagssikt og fremgangsmåte for nedihulls ferdigstilling
AU7692601A (en) Method for treating multiple wellbore intervals
NO20030200L (no) Fremgangsmåte og anordning for å plassere og utspörre nedihullssensorer
NO20014823L (no) Heterocyklus-holdige bifenyl-aP2-inhibitorer og metode
NO20032845D0 (no) Fremgangsmåte og anordning for nedihullsoperasjoner
EP1097165A4 (en) NEW INHIBITORS OF ANGIOGENESIS AND TUMOR GROWTH
NO20015764L (no) Fremgangsmåte og preparat for å maskere mineralsmak
GB2358962B (en) Method of using magnetic lifting devices
NO20011026D0 (no) Matvare og fremgangsmÕte for fremstilling derav
NO20025094L (no) System og fremgangsmåte for stigerör-tilbaketrekkingsstyring
NO20024576L (no) Fremgangsmate for a inhibere angiogenese og tumorvekst
PL346034A1 (en) Method of obtaining substituted banzoylcyanide aminohydrazones
ID30377A (id) Metoda pengobatan neurodegenerasi
NO20023959D0 (no) Flateelement og fremgangsmåte for fremstilling av et flateelement
IS2685B (is) Aðferð og búnaður fyrir botnnema
EP1267911A4 (en) TREATMENT METHOD
IL142256A0 (en) Method of treating a parasitic infection
GB2371808B (en) Method of planting trees
NO20026067L (no) Systemer og fremgangsmåter for behandling av en slimhinneoverflate
GB0026834D0 (en) Method for detecting inhibitors of tumour growth
PL344620A1 (en) 1-alkoxymethyl-3-y-pyridinium salts and method of obtaining them _
AU3713201A (en) A method of treatment
NO20001694D0 (no) Vekstanordning for skjell og skalldyr

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application